Cover Image
市場調查報告書

Nordic Bioscience a/s的產品平台分析

Nordic Bioscience A/S - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 321975
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
Nordic Bioscience a/s的產品平台分析 Nordic Bioscience A/S - Product Pipeline Review - 2015
出版日期: 2015年10月21日 內容資訊: 英文 27 Pages
簡介

Nordic Bioscience a/s是總公司設立於丹麥的生物科技企業,從事著使用血清之研究開發用疾病特異性生物化學標記的開發。

本報告提供Nordic Bioscience a/s 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Nordic Bioscience a/s 基本資料

  • Nordic Bioscience a/s 概要
  • 主要資訊
  • 企業資料

Nordic Bioscience a/s :R&D概要

  • 主要的治療範圍

Nordic Bioscience a/s :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Nordic Bioscience a/s :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Nordic Bioscience a/s :藥物簡介

  • KBP-042
  • KBP-056
  • KBP-088
  • UGP-302

Nordic Bioscience a/s :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Nordic Bioscience a/s :最新的開發平台資訊

Nordic Bioscience a/s :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07687CDB

Summary

Global Markets Direct's, 'Nordic Bioscience a/s - Product Pipeline Review - 2015', provides an overview of the Nordic Bioscience a/s's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nordic Bioscience a/s's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Nordic Bioscience a/s including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Nordic Bioscience a/s's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Nordic Bioscience a/s's pipeline products

Reasons to buy

  • Evaluate Nordic Bioscience a/s's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Nordic Bioscience a/s in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Nordic Bioscience a/s's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Nordic Bioscience a/s and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nordic Bioscience a/s
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Nordic Bioscience a/s and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Nordic Bioscience A/S Snapshot
    • Nordic Bioscience A/S Overview
    • Key Information
    • Key Facts
  • Nordic Bioscience A/S - Research and Development Overview
    • Key Therapeutic Areas
  • Nordic Bioscience A/S - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Nordic Bioscience A/S - Pipeline Products Glance
    • Nordic Bioscience A/S - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Nordic Bioscience A/S - Drug Profiles
    • KBP-042
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • KBP-056
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Salmon Calcitonin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • UGP-302
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Nordic Bioscience A/S - Pipeline Analysis
    • Nordic Bioscience A/S - Pipeline Products by Target
    • Nordic Bioscience A/S - Pipeline Products by Route of Administration
    • Nordic Bioscience A/S - Pipeline Products by Molecule Type
    • Nordic Bioscience A/S - Pipeline Products by Mechanism of Action
  • Nordic Bioscience A/S - Recent Pipeline Updates
  • Nordic Bioscience A/S - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Nordic Bioscience A/S, Key Information
  • Nordic Bioscience A/S, Key Facts
  • Nordic Bioscience A/S - Pipeline by Indication, 2015
  • Nordic Bioscience A/S - Pipeline by Stage of Development, 2015
  • Nordic Bioscience A/S - Monotherapy Products in Pipeline, 2015
  • Nordic Bioscience A/S - Partnered Products in Pipeline, 2015
  • Nordic Bioscience A/S - Partnered Products/ Combination Treatment Modalities, 2015
  • Nordic Bioscience A/S - Preclinical, 2015
  • Nordic Bioscience A/S - Pipeline by Target, 2015
  • Nordic Bioscience A/S - Pipeline by Route of Administration, 2015
  • Nordic Bioscience A/S - Pipeline by Molecule Type, 2015
  • Nordic Bioscience A/S - Pipeline Products by Mechanism of Action, 2015
  • Nordic Bioscience A/S - Recent Pipeline Updates, 2015

List of Figures

  • Nordic Bioscience A/S - Pipeline by Top 10 Indication, 2015
  • Nordic Bioscience A/S - Partnered Products in Pipeline, 2015
  • Nordic Bioscience A/S - Pipeline by Top 10 Target, 2015
  • Nordic Bioscience A/S - Pipeline by Top 10 Molecule Type, 2015
  • Nordic Bioscience A/S - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top